Australia markets open in 9 hours 21 minutes

Factor Therapeutics Limited (FTT.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.00500.0000 (0.00%)
At close: 10:02AM AEST
Currency in AUD

Valuation measures

Market cap (intra-day) 55.21M
Enterprise value 31.75M
Trailing P/E
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)7.83
Price/book (mrq)1.67
Enterprise value/revenue 32.63
Enterprise value/EBITDA 66.99

Trading information

Stock price history

Beta (5Y monthly) 0.57
52-week change 366.67%
S&P500 52-week change 317.60%
52-week high 30.0070
52-week low 30.0010
50-day moving average 30.0050
200-day moving average 30.0050

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 51.04B
Float 452.88M
% held by insiders 141.76%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:1
Last split date 304 Feb 2009

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2019
Most-recent quarter (mrq)30 Jun 2020

Profitability

Profit margin 40.59%
Operating margin (ttm)37.29%

Management effectiveness

Return on assets (ttm)4.39%
Return on equity (ttm)8.00%

Income statement

Revenue (ttm)665.82k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-73.20%
Gross profit (ttm)2.41M
EBITDA 250.47k
Net income avi to common (ttm)270.28k
Diluted EPS (ttm)0.0000
Quarterly earnings growth (yoy)-69.00%

Balance sheet

Total cash (mrq)3.46M
Total cash per share (mrq)0
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)83.12
Book value per share (mrq)0.00

Cash flow statement

Operating cash flow (ttm)95.68k
Levered free cash flow (ttm)-15.67k